The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease is characterized by a widespread functional disturbance of the human brain. Fibrillar amyloid proteins are deposited inside neurons as neurofibrillary tangles and extracellularly as amyloid plaque cores and in blood vessels. The major protein subunit (A4) of the amyloid fibril of tangles, plaques and blood vessel deposits is an insoluble, highly aggregating small polypeptide of relative molecular mass 4,500. The same polypeptide is also deposited in the brains of aged individuals with trisomy 21 (Down's syndrome). We have argued previously that the A4 protein is of neuronal origin and is the cleavage product of a larger precursor protein. To identify this precursor, we have now isolated and sequenced an apparently full-length complementary DNA clone coding for the A4 polypeptide. The predicted precursor consists of 695 residues and contains features characteristic of glycosylated cell-surface receptors. This sequence, together with the localization of its gene on chromosome 21, suggests that the cerebral amyloid deposited in Alzheimer's disease and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Molecular imaging studies such as those using amyloid positron emission tomography (PET) have shown that Aβ deposition reaches a plateau before brain atrophy can be identified from structural magnetic resonance imaging (MRI) and cognitive symptoms [15, 19].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“All the mutant genes of hereditary, autosomal, and dominant familial AD, including amyloid precursor protein (APP), presenilin 1, and presenilin 2, encode the major proteins involved in amyloid metabolism [14–16].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“Amyloid  protein (A), the principal protein in the senile plaques of Alzheimer's disease (AD), is an ϳ4 kDa secreted polypeptide”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Kang et al., 1987
In the citing paper
“APP isoforms are encoded by several alternatively spliced transcripts (Kang et al., 1987;K itaguchi et al., 1988;Ponte et al., 1988;Tanzi et al., 1988;Golde et al., 1990;Ko ¨nig et al., 1992).”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Kang et al., 1987
In the citing paper
“APP, first identified by Kang et al. [18], is a type I transmembrane protein with a long luminal N-terminal domain and a small cytoplasmic C-terminal tail [18,19].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [18]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,401
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,751
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Self-citationLehrach, H., Diamond, D., Wozney, J. M., & Boedtker, H. (1977) · Biochemistry · doi:10.1021/bi00640a033 · Cited by 3,415
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
A cellular gene encodes scrapie PrP 27-30 protein
Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90333-2 · Cited by 1,513
Research works printed but not linked: 4
- Alzheimer, A. Allg. Z. Psychiat. 64, 146–148 (1907).
- Katzman, R. (ed.) Biological Aspects of Alzheimer's Disease (Banbury Report 15) (Cold Spring Harbor Laboratory, New York, 1983).
- Beyreuther, K. et al. in Discussions in Neuroscience Vol. 3 (eds Bignami, A., Bolis, L. & Gajdusek, D. C. 68–79 Fondation pour I'Étude du Système Nerveux, Geneva (1986).
- Goldgaber, D., Lerman, M. I., McBride, W. O., Sallow, V. & Gajdusek, D. C. Science (in the press).
Cited by
Items 401–500 of 1,071
Rockenstein, E. M., McConlogue, L., Tan, H., Power, M., Masliah, E., & Mucke, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28257 · Cited by 259
Lorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B., & Yankner, B. A. (2000) · Nature Neuroscience · doi:10.1038/74833 · Cited by 258
“The structure of APP suggests that it may function as a cell surface recepto”
BackgroundBiomarkers of postoperative delirium and cognitive dysfunction
Androsova, G., Krause, R., Winterer, G., & Schneider, R. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00112 · Cited by 257
An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing.
Sanke, T., Bell, G. I., Sample, C., Rubenstein, A. H., & Steiner, D. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77825-9 · Cited by 258
Genomic organization of the human amyloid beta-protein precursor gene
Yoshikai, S.-I., Sasaki, H., Doh-ura, K., Furuya, H., & Sakaki, Y. (1990) · Gene · doi:10.1016/0378-1119(90)90310-n · Cited by 258
Forloni, G., Demicheli, F., Giorgi, S., Bendotti, C., & Angeretti, N. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90202-m · Cited by 256
Alzheimer's disease: a re-examination of the amyloid hypothesis
Neve, R. L., & Robakis, N. K. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01168-5 · Cited by 256
Amyloid Protein Precursor Messenger RNAs: Differential Expression in Alzheimer's Disease
Palmert, M. R., Golde, T. E., Cohen, M. L., Kovacs, D. M., Tanzi, R. E., Gusella, J. F., Usiak, M. F., Younkin, L. H., & Younkin, S. G. (1988) · Science · doi:10.1126/science.2457949 · Cited by 256
Palmert, M. R., Podlisny, M. B., Witker, D. S., Oltersdorf, T., Younkin, L. H., Selkoe, D. J., & Younkin, S. G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6338 · Cited by 255
Mobley, W. C., Neve, R. L., Prusiner, S. B., & McKinley, M. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9811 · Cited by 255
Sharples, R. A., Vella, L. J., Nisbet, R. M., Naylor, R., Perez, K., Barnham, K. J., Masters, C. L., & Hill, A. F. (2008) · The FASEB Journal · doi:10.1096/fj.07-9357com · Cited by 254
“APP is an integral membrane protein with a single membrane-spanning domain, a large extracellular amino terminus and a short cytoplasmic carboxyl terminus (8, 9).”
Self-citationEffects of injected Alzheimer beta-amyloid cores in rat brain.
Frautschy, S. A., Baird, A., & Cole, G. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8362 · Cited by 254
Relation of Neuronal APP-751/APP-695 mRNA Ratio and Neuritic Plaque Density in Alzheimer's Disease
Johnson, S. A., McNeill, T., Cordell, B., & Finch, C. E. (1990) · Science · doi:10.1126/science.2111579 · Cited by 253
Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update
Huang, L.-K., Kuan, Y.-C., Lin, H.-W., & Hu, C.-J. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00976-6 · Cited by 252
Wisniewski, T., Ghiso, J., & Frangione, B. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91706-i · Cited by 249
Beta amyloid precursor protein mediates neuronal cell‐cell and cell‐surface adhesion
Breen, K. C., Bruce, M., & Anderton, B. H. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280109 · Cited by 249
Fraser, P. E., Nguyen, J. T., Inouye, H., Surewicz, W. K., Selkoe, D. J., Podlisny, M. B., & Kirschner, D. A. (1992) · Biochemistry · doi:10.1021/bi00159a011 · Cited by 248
The βA4 amyloid precursor protein binding to copper
Hesse, L., Beher, D., Masters, C. L., & Multhaup, G. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00658-x · Cited by 248
Self-citationConformational transition of amyloid β-peptide
Xu, Y., Shen, J., Luo, X., Zhu, W., Chen, K., Ma, J., & Jiang, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501218102 · Cited by 247
Yuzwa, S. A., & Vocadlo, D. J. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00038b · Cited by 247
Choline metabolism as a basis for the selective vulnerability of cholinergic neurons
Wurtman, R. J. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90351-8 · Cited by 246
Alzheimer's disease and Down's syndrome
MANN, D. M. A. (1988) · Histopathology · doi:10.1111/j.1365-2559.1988.tb02018.x · Cited by 245
Cellular Functions of the Amyloid Precursor Protein from Development to Dementia
van der Kant, R., & Goldstein, L. S. B. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.022 · Cited by 245
Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein
Van Nostrand, W. E., Melchor, J. P., Cho, H. S., Greenberg, S. M., & Rebeck, G. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104135200 · Cited by 245
Heparin in Inflammation: Potential Therapeutic Applications beyond Anticoagulation
Tyrrell, D. J., Horne, A. P., Holme, K. R., Preuss, J. M. H., & Page, C. P. (1999) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60471-8 · Cited by 245
Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease
Crouch, P. J., Harding, S.-M. E., White, A. R., Camakaris, J., Bush, A. I., & Masters, C. L. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.07.013 · Cited by 244
Self-citationAmyloid precursor protein promotes post‐developmental neurite arborization in the Drosophila brain
Leyssen, M., Ayaz, D., Hébert, S. S., Reeve, S., De Strooper, B., & Hassan, B. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600757 · Cited by 245
“In this study, we focus on the amyloid precursor protein (APP), which is the precursor of Ab in mammals (Kang et al, 1987).”
BackgroundOgomori, K., Kitamoto, T., Tateishi, J., Sato, Y., Suetsugu, M., & Abe, M. (1989) · Europe PMC (PubMed Central) · Cited by 245
Calcium Ionophore Increases Amyloid .beta. Peptide Production by Cultured Cells
Querfurth, H. W., & Selkoe, D. J. (1994) · Biochemistry · doi:10.1021/bi00181a016 · Cited by 245
The genetics and neuropathology of Alzheimer’s disease
Schellenberg, G. D., & Montine, T. J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0996-2 · Cited by 242
Pappolla, M. A., Chyan, Y. J., Poeggeler, B., Frangione, B., Wilson, G., Ghiso, J., & Reiter, R. J. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050018 · Cited by 243
“APP is highly conserved in evolution and has several postulated functions including growth promoting properties (Ponte et al., 1988), receptor function (Kang et al., 1987) and cell adhesion (Schubert et al., 1989; Breen et al., 1991).”
BackgroundMolecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family
Yamada, H., Watanabe, K., Shimonaka, M., & Yamaguchi, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36998-3 · Cited by 243
Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease
TCW, J., & Goate, A. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024539 · Cited by 242
Parker, M. W., Rossjohn, J., Cappai, R., Feil, S. C., Henry, A., McKinstry, W. J., Galatis, D., Hesse, L., Multhaup, G., Beyreuther, K. T., et al. (1999) · Nature Structural Biology · doi:10.1038/7562 · Cited by 242
Self-citationAbsence of Linkage of Chromosome 21q21 Markers to Familial Alzheimer's Disease
Schellenberg, G. D., Bird, T. D., Wijsman, E. M., Moore, D. K., Boehnke, M., Bryant, E. M., Lampe, T. H., Nochlin, D., Sumi, S. M., Deeb, S. S., et al. (1988) · Science · doi:10.1126/science.3420406 · Cited by 242
Self-citationMolecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
Masters, C. L., Cappai, R., Barnham, K. J., & Villemagne, V. L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03989.x · Cited by 241
“The amyloid precursor protein gene was cloned following the purification and sequencing of the Ab peptide from Alzheimer’s disease brains and is localised to chromosome 21 (Kang et al. 1987), the chromosome involved in Down’s syndrome, a condition that invariably develops the typical Alzheimer’s disease neuropathology…”
BackgroundMethodInfluentialSelf-citationYamada, K., Tanaka, T., Han, D., Senzaki, K., Kameyama, T., & Nabeshima, T. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00408.x · Cited by 238
“Transgenic mice, which overexpress human APP containing the mutations associated with familial AD, develop many of the pathological characterizations associated with AD (Gameset al., 1995; Johnson-Woodet al., 1997; Sturchler-Pierratet al., 1997).”
BackgroundInfluentialThe road to the synthesis of “difficult peptides”
Paradís-Bas, M., Tulla-Puche, J., & Albericio, F. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00680e · Cited by 235
Ermekova, K. S., Zambrano, N., Linn, H., Minopoli, G., Gertler, F., Russo, T., & Sudol, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.32869 · Cited by 236
Sabo, S. L., Ikin, A. F., Buxbaum, J. D., & Greengard, P. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.7.1403 · Cited by 237
“It has also been suggested that APP might have a role in signal transduction since APP structurally resembles a receptor (Kang et al., 1987) and is targeted to the cell surface.”
BackgroundDisulfides as Redox Switches: From Molecular Mechanisms to Functional Significance
Wouters, M. A., Fan, S. W., & Haworth, N. L. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2510 · Cited by 234
Reduced levels of amyloid β-peptide antibody in Alzheimer disease
Du, Y., Dodel, R., Hampel, H., Buerger, K., Lin, S., Eastwood, B., Bales, K., Gao, F., Moeller, H. –., Oertel, W., et al. (2001) · Neurology · doi:10.1212/wnl.57.5.801 · Cited by 235
Diffuse type of senile plaques in the brains of Alzheimer-type dementia
Yamaguchi, H., Hirai, S., Morimatsu, M., Shoji, M., & Harigaya, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00687420 · Cited by 235
“A rabbit was immunized with a synthetic/3 peptide (1-28; [10]), coupled to keyhole limpet hemocyanin.”
MethodIijima, K., Ando, K., Takeda, S., Satoh, Y., Seki, T., Itohara, S., Greengard, P., Kirino, Y., Nairn, A. C., & Suzuki, T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751085.x · Cited by 234
“, 1998), an integral membrane protein (Kang et al., 1987) that is phosphorylated in the cytoplasmic (Suzuki et al.”
BackgroundNovel Research Horizons for Presenilins and γ-Secretases in Cell Biology and Disease
De Strooper, B., & Annaert, W. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-104117 · Cited by 234
Lichtenthaler, S. F., Wang, R., Grimm, H., Uljon, S. N., Masters, C. L., & Beyreuther, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3053 · Cited by 234
Self-citationIntracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.
Knauer, M. F., Soreghan, B., Burdick, D., Kosmoski, J., & Glabe, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7437 · Cited by 233
Amyloid β-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro
Gregori, L., Fuchs, C., Figueiredo-Pereira, M. E., Van Nostrand, W. E., & Goldgaber, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19702 · Cited by 233
Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease
Jeong, S. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.0096 · Cited by 233
“In the 1980s, amyloid -peptide (A) and hyperphosphorylated tau (pTau) were recovered as major components of, respectively, neuritic plaques and NFTs of AD (Grundke-Iqbal et al., 1986; Ihara et al., 1986; Kang et al., 1987; Kosik et al., 1986; Masters et al., 1985).”
BackgroundRebeck, G. W., Harr, S. D., Hyman, B. T., & Strickland, D. K. (1995) · Annals of Neurology · doi:10.1002/ana.410370212 · Cited by 232
Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands
Tjernberg, L. O., Lilliehöök, C., Callaway, D. J. E., Näslund, J., Hahne, S., Thyberg, J., Terenius, L., & Nordstedt, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12601 · Cited by 231
Wertkin, A. M., Turner, R. S., Pleasure, S. J., Golde, T. E., Younkin, S. G., Trojanowski, J. Q., & Lee, V. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9513 · Cited by 231
Down patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques
Giaccone, G., Tagliavini, F., Linoli, G., Bouras, C., Frigerio, L., Frangione, B., & Bugiani, O. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90169-9 · Cited by 231
Dementia, stroke, and vascular risk factors; a review
Sahathevan, R., Brodtmann, A., & Donnan, G. A. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00731.x · Cited by 230
Glaucoma ocular Alzheimer s disease
McKinnon, S. J. (2003) · Frontiers in Bioscience · doi:10.2741/1172 · Cited by 228
Characterization of Alzheimer's β-Secretase Protein BACE
Haniu, M., Denis, P., Young, Y., Mendiaz, E. A., Fuller, J., Hui, J. O., Bennett, B. D., Kahn, S., Ross, S., Burgess, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002095200 · Cited by 229
Walter, J., Capell, A., Grünberg, J., Pesold, B., Schindzielorz, A., Prior, R., Podlisny, M. B., Fraser, P., St. George Hyslop, P., Selkoe, D. J., et al. (1996) · Molecular Medicine · doi:10.1007/bf03401652 · Cited by 229
Wurth, C., Guimard, N. K., & Hecht, M. H. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00399-6 · Cited by 227
“” The initial purification of Ab from amyloid deposits was reported in the mid 1980s(5,12,13) and the complete amino acid sequence has been known since 1987.(14) Nonetheless, it is not yet clear how this particular sequence drives Ab to selfassemble into aggregated fibrillar structures.”
BackgroundPrevalence of Alzheimer plaques in AIDS
Esiri, M. M., Biddolph, S. C., & Morris, C. S. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.1.29 · Cited by 227
Hashimoto, T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1524 · Cited by 227
Stéphan, A., Laroche, S., & Davis, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05703.2001 · Cited by 225
“Ab is a 4 kDa peptide of 42/43 amino acids, harbored within the larger, transmembranal amyloid precursor protein (APP) and located in the portion of the protein that spans the transmembranal domain (Glenner and Wong, 1984; Kang et al., 1987).”
BackgroundLing, Y., Morgan, K., & Kalsheker, N. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00133-x · Cited by 224
Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer Disease
Jawhar, S., Wirths, O., & Bayer, T. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.288308 · Cited by 218
Daigle, I., & Li, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12045 · Cited by 222
Goedert, M. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02694.x · Cited by 222
Beyreuther, K., & Masters, C. L. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00667.x · Cited by 221
Self-citationWhite, A. R., Multhaup, G., Maher, F., Bellingham, S., Camakaris, J., Zheng, H., Bush, A. I., Beyreuther, K., Masters, C. L., & Cappai, R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09170.1999 · Cited by 222
“, 1985) derived by proteolytic processing of full-length amyloid precursor protein (APP) (Kang et al., 1987).”
BackgroundSelf-citationRegulation of Amyloid Precursor Protein Cleavage
Mills, J., & Reiner, P. B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720443.x · Cited by 221
“APP comprises a family of type 1 membrane-spanning glycoproteins (Kang et al., 1987; Tanzi et al., 1987); alternative splicing generates APP mRNAs giving rise to isoforms ranging from 365–770 amino acid residues (Kosik, Address correspondence and reprint requests to Dr. P. B. Reiner at Kinsmen…”
BackgroundDocosahexaenoic Acid Reduces Amyloid β Production via Multiple Pleiotropic Mechanisms
Grimm, M. O. W., Kuchenbecker, J., Grösgen, S., Burg, V. K., Hundsdörfer, B., Rothhaar, T. L., Friess, P., de Wilde, M. C., Broersen, L. M., Penke, B., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182329 · Cited by 220
Gandy, S., Czernik, A. J., & Greengard, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6218 · Cited by 220
Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion
Nitsch, R. M., Deng, M., Growdon, J. H., & Wurtman, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4188 · Cited by 219
“The amyloid precursor protein (APP)1 is an ubiquitous membrane-spanning glycoprotein (Kang et al., 1987; Weidemann et al., 1989) that is present at high levels in brain cells.”
BackgroundMandal, P. K., Pettegrew, J. W., Masliah, E., Hamilton, R. L., & Mandal, R. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9140-9 · Cited by 219
“These synaptic membrane-bound a-Syn can also interact with membrane-associated Ab40 and Ab42 peptides [47].”
BackgroundCleavage of Amyloid-β Precursor Protein and Amyloid-β Precursor-like Protein by BACE 1
Li, Q., & Südhof, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310001200 · Cited by 180
Podlisny, M. B., Tolan, D. R., & Selkoe, D. J. (1991) · PubMed Central · Cited by 244
Freude, S., Hettich, M. M., Schumann, C., Stöhr, O., Koch, L., Köhler, C., Udelhoven, M., Leeser, U., Müller, M., Kubota, N., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-132043 · Cited by 218
Oxidative stress potentiates BACE1 gene expression and A? generation
Tong, Y., Zhou, W., Fung, V., Christensen, M. A., Qing, H., Sun, X., & Song, W. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0255-3 · Cited by 218
“Recent molecular genetic studies have shown that four genes confer susceptibility to AD: APP gene on chromosome 21 (Kang et al., 1987); Apo E gene on chromosome 19 (Strittmatter et al., 1993); Presenilin 1 (PS1) on chromosome 14 (Schellenberg et al., 1992; St George-Hyslop et al., 1992; Sherrington…”
BackgroundScheuermann, S., Hambsch, B., Hesse, L., Stumm, J., Schmidt, C., Beher, D., Bayer, T. A., Beyreuther, K., & Multhaup, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105410200 · Cited by 217
Self-citationKönig, G., Mönning, U., Czech, C., Prior, R., Banati, R., Schreiter-Gasser, U., Bauer, J., Masters, C. L., & Beyreuther, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50090-4 · Cited by 217
Self-citationFluorescent-conjugated polymer superquenching facilitates highly sensitive detection of proteases
Kumaraswamy, S., Bergstedt, T., Shi, X., Rininsland, F., Kushon, S., Xia, W., Ley, K., Achyuthan, K., McBranch, D., & Whitten, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402367101 · Cited by 216
Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic Stroke
Hesse, C., Rosengren, L., Vanmechelen, E., Vanderstichele, H., Jensen, C., Davidsson, P., & Blennow, K. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-23-402 · Cited by 216
Suzuki, T., Oishi, M., Marshak, D. R., Czernik, A. J., Nairn, A. C., & Greengard, P. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06360.x · Cited by 216
α 2 -macroglobulin associates with β-amyloid peptide and prevents fibril formation
Hughes, S. R., Khorkova, O., Goyal, S., Knaeblein, J., Heroux, J., Riedel, N. G., & Sahasrabudhe, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3275 · Cited by 216
The role of APP and BACE1 trafficking in APP processing and amyloid-β generation
Zhang, X., & Song, W. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt211 · Cited by 213
A Substrate-Based Difluoro Ketone Selectively Inhibits Alzheimer's γ-Secretase Activity
Wolfe, M. S., Citron, M., Diehl, T. S., Xia, W., Donkor, I. O., & Selkoe, D. J. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970621b · Cited by 215
A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor.
Rosen, D. R., Martin-Morris, L., Luo, L. Q., & White, K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2478 · Cited by 215
Oxidative stress and neurodegenerative disorders
Sun, A. Y., & Chen, Y.-M. (1998) · Journal of Biomedical Science · doi:10.1007/bf02255928 · Cited by 215
The Non-Amyloidogenic Pathway: Structure and Function of α-Secretases
Kojro, E., & Fahrenholz, F. (2006) · Subcellular Biochemistry · doi:10.1007/0-387-23226-5_5 · Cited by 213
Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines
Puzzo, D., Lee, L., Palmeri, A., Calabrese, G., & Arancio, O. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.011 · Cited by 213
“to the identification and sequencing of the amyloid precursor protein (APP), from which Ab is produced [10].”
BackgroundDistinct Early Folding and Aggregation Properties of Alzheimer Amyloid-β Peptides Aβ40 and Aβ42
Chen, Y.-R., & Glabe, C. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602363200 · Cited by 214
Weidemann, A., Paliga, K., Dürrwang, U., Czech, C., Evin, G., Masters, C. L., & Beyreuther, K. (1997) · Nature Medicine · doi:10.1038/nm0397-328 · Cited by 214
Self-citationLink, C. D. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.059 · Cited by 213
Trophic effect of β-amyloid precursor protein on cerebral cortical neurons in culture
Araki, W., Kitaguchi, N., Tokushima, Y., Ishii, K., Aratake, H., Shimohama, S., Nakamura, S., & Kimura, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81412-3 · Cited by 213
Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells
Anderson, J. P., Esch, F. S., Keim, P. S., Sambamurti, K., Lieberburg, I., & Robakis, N. K. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90775-o · Cited by 213
Chung, H., Brazil, M. I., Soe, T. T., & Maxfield, F. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32301 · Cited by 212
Transgenic models of Alzheimer’s disease: Learning from animals
Spires, T. L., & Hyman, B. T. (2005) · NeuroRX · doi:10.1602/neurorx.2.3.423 · Cited by 212
“In 1987, Kang et al.(11) showed that the amyloid in senile plaques is derived from the amyloid precursor protein (APP).”
Fraser, P. E., Nguyen, J. T., Chin, D. T., & Kirschner, D. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08470.x · Cited by 212
Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease
Behl, C. (1997) · Cell and Tissue Research · doi:10.1007/s004410050955 · Cited by 211
Molecular biology and genetics of Alzheimer's disease
St George-Hyslop, P. H., & Petit, A. (2005) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2004.10.013 · Cited by 210
Eggert, S., Paliga, K., Soba, P., Evin, G., Masters, C. L., Weidemann, A., & Beyreuther, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311601200 · Cited by 209
Self-citationβ-Secretase (BACE) as a drug target for alzheimer’s disease
Vassar, R. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00157-6 · Cited by 210
Metadata
- Authors
- Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B.
- Affiliations
- University of Cologne (DE)
- Venue
- Nature
- Published
- 1987-02
- Volume
- 325
- Issue
- 6106
- Pages
- 733-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2081881251
- Cited by
- 4,619
- References
- 26
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 63 · 2023: 71 · 2022: 54 · 2021: 79 · 2020: 82 · 2019: 76 · 2018: 76 · 2017: 98 · 2016: 111 · 2015: 90 · 2014: 97 · 2013: 119 · 2012: 126
- FWCI
- 164.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid precursor protein, cell surface receptors, Down syndrome, amyloid plaques, neurofibrillary tangles, chromosome 21, cDNA cloning, protein sequences
- MeSH terms
- Alzheimer Disease, Amyloid, Base Sequence, Brain, Brain Chemistry, Chromosomes, Human, Pair 21, DNA, Down Syndrome, Fetus, Humans, Neurofibrils, Nucleic Acid Hybridization, Protein Precursors, Protein Processing, Post-Translational, RNA, Messenger, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.